Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 6, 2010 (rev. 1)


Response Genetics this week named David O'Toole as vice president and chief financial officer.

O'Toole has more than 25 years of accounting and finance experience primarily focused on global companies and the life science and biotechnology industries, Response said. He most recently served as CFO at Abraxis Biosciences. Prior to that, he was a partner at Deloitte & Touche. O'Toole holds a BS degree in accounting from the University of Arizona.

Christian Henry has become general manager of the life sciences business unit of Illumina. Henry's appointment is in addition to his other positions of senior vice president and chief financial officer.

In addition, Illumina has appointed Emily Winn-Deen as vice president for diagnostics development. Winn-Deen will be responsible for developing diagnostics products at Illumina. Previously, she was president of consulting practice Rx Dx Advisors. Before that, she held vice president positions in genetics and oncology R&D, and in strategic development and business planning at Cepheid. In the past, she held senior R&D positions at Roche Molecular Systems, Applera, Oncor, and Bayer Diagnostics. Winn-Deen holds a PhD in chemistry from Boston University and a BA in chemistry from Lehigh University.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.